322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids
The Readout Loud
00:00
Navigating Clinical Trials and FDA Approvals for Cancer Treatments
This chapter explores the clinical and regulatory processes Summit faces in advancing their cancer treatment trials, with an emphasis on recruiting US participants. It also examines the typical FDA approval strategies and deliberates on potential alternative routes in light of recent trial outcomes.
Transcript
Play full episode
